Who’s Hired? Former Hikma Chief Olafsson Takes Lead At Mallinckrodt

As Teva Names New Global R&D And Chief Medical Officer

Siggi Olafsson has taken the reins at Mallinckrodt after stepping down as Hikma’s CEO. At the same time, Teva has named a new global R&D and chief medical officer while Piramal Pharma Solutions has appointed a fresh COO and Formycon has added to its supervisory board.

R&D Wooden Blocks
Teva has named a new global R&D and chief medical officer • Source: Shutterstock

More from Leadership

More from Generics Bulletin